Back
For best output, select "Paper Size" as "A4" and "Margin" as "0" or "None".
To save or print to PDF, please select Print Destination > Save as PDF, enable Background Graphics under "More Settings", then click "Save".
During the congress, E-Posters will be accessible to all participants on the congress website 24/7, as well as in the E-poster stations in the congress center.
Preparing your E-Poster
Please review the E-Poster format requirements carefully when preparing your E-Poster. Should your E-Poster not meet the mentioned requirements, it may not be displayed as described above.
E-Poster Submission Deadline
Please prepare and upload your E-Poster no later than March 14, 2026 11.59PM CET. After this date, you will no longer be able to prepare and upload your E-poster and it will not be displayed and accessible on the congress website.
Please follow the instructions below to input your abstract title.
Abstract titles should be brief and reflect the content of the abstract.
The burden of kidney diseases is increasing world-wide. The prevalence of chronic kidney disease in general population is 1:10. And that of other form of kidney diseases varies from country to country depending on its etiology. This study aimed to assess the prevalence, etiology and their co-morbid state of hospitalized patients with kidney diseases in 1,000 bedded public hospital caring both medical and surgical cases.
A hospital based descriptive study was conducted among hospitalized patients at 1,000 bedded tertiary hospital, Mingaladon, Myanmar from February 2024 to May 2024. Data were collected by using standardized forms and analysis was done.
The study population comprises 1885 hospitalized patients. The prevalence of patients with kidney diseases was 20% of total hospitalized patients; high burden. Gender distribution of 71.6% male and 28.4% female. The age ranged from 18 years to 95 years. The most common age group was 45 to 59 years.
The frequency distribution of kidney diseases in order of frequency were as follows: urolithiasis (50%, 188/377); end stage renal disease (CKD Stage 4 & 5) (21%, 78/377); hydronephrosis due to ureteric stone (7%, 21/377); living donor kidney transplant recipient and donor (6%, 21/377); chronic kidney disease (CKD Stage 1, 2 & 3) (10%, 36/377); renal cell carcinoma (2%, 6/377); nephrotic syndrome (2%, 6/377); renal cyst (1%, 4/377); benign prostatic hypertrophy (1%, 4/377); acute glomerulonephritis (0.5%, 2/377); AKI acute kidney injury (0.5%, 2/377); and adult polycystic kidney disease (0.2%, 1/377).
Nearly half of the patients with kidney disease (45.1%) did not have co-morbidity. And over fifty percent of them (54.9%) had associated co-morbid diseases; one third (32.8%) had two co-morbid diseases; one fifth (17%) had three co-morbid diseases; less than 5% ( 4.5%) had four co-morbid diseases; and less than 1% (0.6%) had five co-morbid diseases. Regarding associated co-morbid conditions, hypertension was the most common (34.9%), followed by ischemic heart disease (19.4%) and diabetes mellitus (16.7%). Cerebrovascular accidents (8%) and autoimmune disorders (3%) were less prevalent.
Table (1) Age distribution of Kidney Diseases (n=377)
Age groups
Frequency
Percentage (%)
Below 18 years
2
0.53
18-34 years
77
20.42
35-44 years
92
24.40
45-59 years
124
32.89
60 years & above
82
21.75
Total
377
100
Table (2) Distribution of number of co-morbid diseases in patient with Kidney Diseases (n=377)
Table (3) Distribution of Kidney Diseases (n=377)
No.
Kidney Diseases
1
Stones (Renal stone, Ureteric stone, Vesicle stone)
188
50
End Stage Renal Disease (CKD Stage 4 & 5)
78
20.74
3
Hydronephrosis due to stone
27
7.18
4
Renal Transplant
21
5.58
5
Chronic Kidney Disease (Stage 1, 2 & 3)
36
9.55
6
Renal Cell Carcinoma
1.59
7
Nephrotic syndrome
8
Renal Cyst
1.06
9
Benign prostatic hypertrophy
10
Acute Glomerulonephritis
11
AKI Acute Kidney Injury
12
Adult Polycystic Kidney Disease
0.26
13
Renal Mass
The burden of kidney diseases was high; occupying one fifth of hospitalized cases in 1,000 bedded tertiary hospital in Myanmar. More than half of patients with kidney diseases had co-morbid diseases. Hypertension, ischemic heart disease, diabetes mellitus and cerebrovascular accidents were common co-morbid conditions. Urolithiasis was seen in half of cases and chronic kidney diseases was seen in one third of cases. This study may give guidance on making health policy on prevention and treatment of non-communicable diseases at primary health care level in Myanmar.
